My son Keaton reports: Oklahoma opioid trial has national implications

My son Keaton is a general reporting intern for The Oklahoman.

I was excited to see his story on the national implications of an ongoing trial against opioid manufacturer Johnson & Johnson at the top of Sunday’s front page.

Keaton, a 22-year-old journalism major, will be a senior this fall at Oklahoma Christian University, where he will serve as editor-in-chief of the student newspaper The Talon.

From @keaton__ross: With billions of dollars and historic legal precedent on the line, all eyes are on Oklahoma's opioid trial https://t.co/RCzVoDvG99

— NewsOK (@NewsOK) June 30, 2019